NACB Diabetes Guidelines Cautious On Less-Invasive Glucose Monitoring
This article was originally published in The Gray Sheet
Executive Summary
"Routine" minimally invasive glucose sensing with Cygnus' GlucoWatch Biographer and MiniMed's CGMS continuous glucose monitor system is not recommended by the National Academy of Clinical Biochemistry (NACB) in a recent draft of the group's diabetes management guidelines.
You may also be interested in...
NACB diabetes guidelines
Glycated hemoglobin should be measured at least biannually in diabetic patients to document glycemic control, according to National Academy of Clinical Biochemistry (NACB) guidelines to be published in the March issue of Clinical Chemistry. Entitled "Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus," the guidelines were released in draft form in 2000 (1"The Gray Sheet" Aug. 7, 2000, p. 14). Authored by NACB with input from the American Diabetes Association, and approved by the ADA professional practice committee, the guidelines' recommendations also include annual microalbumin testing for pubertal or postpubertal diabetics without clinical proteinuria starting five years after diagnosis of type 1 and at the time of type 2 diagnosis. The document also recommends an annual lipid profile for diabetic adults...
NACB diabetes guidelines
Glycated hemoglobin should be measured at least biannually in diabetic patients to document glycemic control, according to National Academy of Clinical Biochemistry (NACB) guidelines to be published in the March issue of Clinical Chemistry. Entitled "Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus," the guidelines were released in draft form in 2000 (1"The Gray Sheet" Aug. 7, 2000, p. 14). Authored by NACB with input from the American Diabetes Association, and approved by the ADA professional practice committee, the guidelines' recommendations also include annual microalbumin testing for pubertal or postpubertal diabetics without clinical proteinuria starting five years after diagnosis of type 1 and at the time of type 2 diagnosis. The document also recommends an annual lipid profile for diabetic adults...
Cygnus Sizzles In June; Stock Rises 77% On Heels Of Diabetes Conference
The stock prices of diabetes product manufacturers Cygnus and MiniMed headed in opposite directions in the aftermath of the June 9-13 annual meeting of the American Diabetes Association.